Table 1. Clinical findings of 5 patients with pulmonary cavity.
Case | Primary diseases | Gender | Age (years) | MELD | GM test | CBAS | AFBSSS | Diagnosis | Follow-up |
---|---|---|---|---|---|---|---|---|---|
1 | PBC | Female | 54 | 22 | + | Aspergillus(+) | TB(−) | Aspergillus | Die |
2 | Chronic hepatitis B | Male | 61 | 31 | + | Aspergillus(+) | TB(−) | Aspergillus | Cure |
3 | Chronic hepatitis B | Female | 50 | 30 | + | Aspergillus(+) | TB(−) | Aspergillus | Cure |
4 | HCC | Male | 45 | 14 | − | Aspergillus(−) | TB(+) | TB | Cure |
5 | Hepatitis cirrhosis | Male | 38 | 19 | − | Aspergillus(−) | TB(+) | TB | Cure |
PBC, primary biliary cirrhosis; HCC, hepatocellular carcinoma; GM, galactomannan; CBAS, cultures of bronchial aspirates or sputum; AFBSSS, acid-fast bacilli staining of sputum smears; MELD, model for end-stage liver disease.